Events

Meet Cogstate experts at these upcoming industry events around the globe.

Loading Events

« All Events

12th Clinical Trials on Alzheimer’s Disease (CTAD)

December 4 - December 7

The development of the next generation of Alzheimer’s disease treatments is among the most important health needs worldwide, but presents huge challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the next generation of Alzheimer’s disease treatments.

Cogstate Presentations at CTAD 2019

Thursday, Dec 5th

11:30am – Oral Communication

OC5 – Development of cognitive go/no-go decision-making criteria in early clinical development of agents to treat Alzheimer’s disease

Alette Wessels, PhD (1), Chris J. Edgar PhD (2), Gregory Light, PhD (3), Pradeep Nathan, PhD (4), Eric Siemers, MD (5), Paul Maruff, PhD (6), John Harrison, PhD (7)

(1) Eli Lilly and Company, Indianapolis, IN, USA, (2) Cogstate Ltd, London, UK, (3) Department of Psychiatry, University of California, San Diego, USA, (4) SoseiHeptares, Cambridge, UK; Department of Psychiatry, University of Cambridge UK; School of Psychological Sciences, Monash University, Australia, (5) Cogstate Ltd, New Haven, CT, USA, (6) Cogstate Ltd., Melbourne, Australia, (7) Metis Cognition Ltd, Kilmington Common, UK; Alzheimer Center AUmc, Amsterdam, The Netherlands; Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK

 

Saturday, Dec 7th

8:00am – Late Breaking Oral Communication

LB22- Cut points for cognitive decline using MMSE define baseline and longitudinal differences in both clinical and pathological Alzheimer’s disease biomarkers

James Doecke (1), Marcela Cespedes (1), Cai Gillis (2), Nancy Maserejian (2), Pierrick Bourgeat (3), Chris Fowler (4), Victor Villemagne (5), Qiao-Xin Li (4), Steven Collins (4), Stephanie Rainey-Smith (6,7), Paul Maruff (4), Ralph Martins (6,8,9), David Ames (10), Colin Masters (4)

(1) Australian e-Health Research Centre, CSIRO, Australia, (2) Biogen, United States, (3) Australian e-Health Research Centre, CSIRO, Brisbane, QLD, Australia., Australia, (4) The Florey Institute, The University of Melbourne, Australia, (5) Austin Health, Department of Molecular Imaging and Therapy, Center for PET, Australia, (6) Sir James McCusker Alzheimer’s Disease Research Unit (Hollywood Private Hospital), Australia, (7) Centre of Excellence for Alzheimer’s disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Australia, (8) Department of Biomedical Sciences, Macquarie University, Australia, (9) School of Psychiatry and Clinical Neurosciences, University of Western Australia, Australia, (10) National Ageing Research Institute, Australia

 

Register

Contact Us

  • This form collects personal information like your name and email so that we can process your contact request. Please review our Privacy Policy for details on how we protect and manage your submitted data.

  • This field is for validation purposes and should be left unchanged.

Details

Start:
December 4
End:
December 7
Website:
https://www.ctad-alzheimer.com/

Venue

Hilton San Diego Bayfront
1 Park Boulevard, San Diego, CA 92101 United States
+ Google Map